Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: j_fir2 who wrote (2426)	4/19/1999 10:59:00 AM
From: BMcV	Read Replies (1) \| Respond to of 10280

Jennifer, David Maris did figure into a short attack this fall, when he served as the main source for a very negative WSJ article, and it is possible he is involved again. In the fall, he entered into the fray once SEPR had established downward momentum. That is certainly the case now. But that article did mark the turning point, from which SEPR rose 150%. There was such strong buying interest here when the stock corrected from 140 to the 120s that some of those buyers (being on margin) may have been forced to capitulate. It would be a pity if some of our board stalwarts get pushed out of their positions in this great growth opportunity by market manipulation. If I'd known the stock had been downgraded by BS, I would have definitely bought in the 70s, but by the time I found out, the price had recovered to 85.